Minted: - / 5000

540 Entospletinib
ce7bfcbf5acd011575781b8016ccb2994937c4c13e76948ade44773fdc6d8995

Properties

Background

Red
Bottle

Gray
Cap

Yellow
Syringe

Red
Bubbles
No
Drops
No
Label
Leaf

Chemistry

Formula
C23H21N7O
Carbon
23
Polarity
Neutral

Entospletinib is an experimental drug for the treatment of various types of cancer under development by Gilead Sciences. It is an inhibitor of spleen tyrosine kinase (Syk). It has entered clinical trials for acute myeloid leukaemia (AML), chronic lymphocytic leukemia (CLL), diffuse large B cell lymphoma (DLBCL), graft-versus-host disease (GvHD), hematological malignancies, mantle cell lymphoma (MCL), and non-Hodgkin lymphoma (NHL).

From Wikipedia, the free encyclopedia. License: CC BY-SA.